Net Reclassification Index (NRI) = 3.2% (p value 0.08). Patients are categorized into risk categories of death based on their individual survival probabilities obtained from models A and B such that a

NIAID Data Ecosystem50

Supplementary File 3 from TERC Stimulates Fatty Acid Metabolism to Promote Bladder Cancer Progression

膀胱癌临床病理

肿瘤预后评估

Supplementary file 3 lists the clinical information of all bladder cancer patients who provided plasma samples, including age, gender, tumor size and number, stage, grade, NMP22, primary/recurrence, u

NIAID Data Ecosystem40

Whole-body diffusion-weighted magnetic resonance imaging for the detection of bone metastases and their prognostic impact in metastatic renal cell carcinoma patients treated with angiogenesis inhibitors

脑转移影像诊断

肿瘤预后评估

Background: Metastatic renal cell carcinoma (mRCC) patients with bone metastases (BM) are at high risk for skeletal related events and have a poorer outcome when treated with vascular endothelial grow

Figshare2020-04-16 更新50

Performance of Grade III tumors.

肿瘤预后评估

肿瘤临床行为分析

Performance of Grade III tumors.

Figshare2015-12-02 更新40